Bharat Biotech refuse more Covaxin to Delhi, Covishield stock to reach today
New Delhi | There is no stock of -- Covaxin for those between 18-45 of age and around 100 newly setup...
Covishield Vaccine
After SII, Bharat Biotech seeks emergency use nod for Covid vaccine
New Delhi (2 Min Read): Hyderabad-based Bharat Biotech on Monday filed an application with the Drugs Controller General of India (DCGI)...
Covid-19: Phase II trial of Oxford vaccine begins
New Delhi: The Phase II clinical trial of the Oxford Covid-19 vaccine, Covishield, began on Wednesday. The first dose was...
Covishield will be commercialised once trials are successful: SII
New Delhi: Serum Institute of India, has clarified that the current claims surrounding Covishield's availability in the media are completely...
Serum Institute of India to conduct trials of Covishield vaccine
New Delhi: The Serum Institute of India (SII) will launch the first Covid-19 vaccine called 'Covishield' and commence its trials...
